Global Apheresis Market Research Report: Forecast (2024-2030)

Market Definition

Apheresis is a medical procedure that involves removing whole blood from a donor or patient and separating it into its components. After, the separation, a few components (such as plasma, platelets, or white blood cells) are removed from the blood. The remaining components are then returned to the patient's circulation. This medical procedure is often used to treat certain medical conditions. For example, it can be used to collect platelets from donors for transfusion to patients with low platelet counts or to remove harmful substances from the blood, such as antibodies in autoimmune diseases.

Market Insights & Analysis: Global Apheresis Market (2024-30):

The Global Apheresis Market is estimated to grow at a CAGR of around 8.75% during the forecast period, i.e., 2024-30. The market growth has been attributed to the presence of several patients with chronic kidney disorders due to various risk factors, such as obesity, diabetes mellitus, etc., worldwide. For instance,

• In 2023, the International Society of Nephrology mentioned that 850 million people have been affected by chronic kidney disease (CKD) globally.

With that, a preference for therapeutic apheresis as an important adjunctive or alternative therapeutic for primary or secondary kidney diseases & kidney transplantation options besides conventional medical therapies has increased. This has further propelled the growth of the Global Apheresis Market.Furthermore, several prominent market players are laying initiatives to spread awareness about blood donations & transfusions. These transfusions essentially require apheresis machines. Therefore, the escalated demand for blood donations and transfusions worldwide, coupled with rising awareness initiatives to promote blood donations has positively impacted the Apheresis Market. For instance,

• The Governing health authorities marked 14 June as a Blood Donation Day to raise awareness among individuals and encourage them to donate blood to save the lives of other patients.

With the rise in several people willing to donate blood, the demand for apheresis machines & disposable in hospitals and blood banks has witnessed growth, thus propelling the overall Apheresis Market.

Additionally, prominent players across the globe are incorporating emerging technology within their machines, which is enhancing the overall effectiveness and applications of the machine. These expanding applications of apheresis in various medical fields, and favorable reimbursement policies would also aid in enhancing the Apheresis Market size during 2024-30.

Global Apheresis Market Driver:

Increasing Prevalence of Haematological Disorders to Fuel the Apheresis Market – There has been a significant prevalence of various hematological disorders, including leukemia, lymphoma, anemia, sickle cell disease, etc., across the globe, which has propelled the Global Apheresis Market. For instance,

• As per the Global Cancer Observatory, globally there were 82.5 thousand and 553 thousand new cases of Hodgkin lymphoma and Non-Hodgkin lymphoma respectively in 2022, where 487 thousand new cases of leukemia were reported in 2022 globally.

These patients with leukemia and lymphoma do not have enough platelets due to either their disease or their cancer treatment, which damages bone marrow and results in bleeding. Therefore, it becomes critical for them to undergo platelet transfusion, which is possible from apheresis donations. The application of therapeutic apheresis thus helps keep these patients alive while allowing enough time for their therapy to work. As a result, the demand for apheresis machines and disposables has increased and has prolled the overall Apheresis Market growth. Furthermore, the number of anemic patients across the globe is also increasing. For instance,

• The World Health Organization (WHO) reported in 2023 that 40% of all children aged 6–59 months, 37% of pregnant women, and 30% of women aged 15–49 years have been affected by anemia globally.

These patients necessarily require apheresis for effective treatment. Thus, the rising anemic population worldwide is driving the Global Apheresis Market.

Global Apheresis Market Opportunity:

Expansion of Hospitals & Blood Banks Across the Globe to Open New Avenues – Post-COVID-19, governing bodies across the globe have recognized the importance of well-organized and world-class health infrastructure. As a result, official authorities across the globe have been increasingly encouraging the healthcare providers to upgrade their technologies. Thus, hospitals & laboratories worldwide are increasingly buying these medical systems. Further, to strengthen the healthcare infrastructure & improve the quality of living of the inhabitants, the governing bodies are increasingly setting up new medical facilities, including hospitals and blood banks. For instance,  

• In 2022, Dr. Sulaiman Al Habib Medical Services Group announced a new hospital project in Riyadh City, which is expected to be completed by 2025.

These hospitals would be equipped with high-tech medical equipment, including apheresis machines. Therefore, the burgeoning hospital projects across the globe would continue to uplift the demand for apheresis machines, enlarging the Global Apheresis Market size. Further, the number of critical surgeries performed per year is consistently growing. During the surgeries, patients experience blood loss. Therefore, healthcare practitioners require additional blood units. To cater to this growing demand for the blood, the healthcare providers are encouraging blood donations. For instance,

• In 2023, to meet the rising demand for blood & encourage greater donor participation, especially among the youth, a new blood collection center was opened at the One Punggol integrated community hub in Singapore.

These newer facilities would continue to create an opportunity to generate more demand for apheresis systems, allowing healthcare providers to offer appropriate care and treatment to patients efficiently and effectively.

Global Apheresis Market Challenge:

Lack of Skilled Professionals to Perform Apheresis Procedures Impede Market Growth – Apheresis machines are based on the latest technologies. Therefore, to properly operate & manage the machines, the healthcare facilities require individuals with specialized skills and knowledge. The complete procedure from collecting the sample to effectively processing it in a machine requires technical expertise. However, in several regions across the globe, there is a shortage of trained apheresis technicians and nurses. This lack of skilled workforce results in longer wait times for patients requiring apheresis therapy. As a result, patients tend to choose the conventional therapies rather than the apheresis therapies.

Additionally, the unavailability of skilled labor also delays treatment initiation and increases the workload for existing staff, further resulting in compromised patient care. Therefore, hospitals in countries with low technical labor restrain from opting for these medical systems, negatively impacting the demand as well as the growth of the Global Apheresis Market.

Global Apheresis Market Trend:

Growing Focus on Ensuring Safe & Effective Apheresis in Pediatric Settings – The significant prevalence of diseases, such as leukemia and sickle cell disease among pediatric patients highlights the need for specialized equipment to ensure safe & effective apheresis procedures in this demographic. Moreover, the reliance on medical devices, including apheresis machines, predominantly approved for adult use poses safety and efficacy concerns when utilized for pediatric patients.

Consequently, researchers, companies, and major organizations are directing efforts toward the development of dedicated pediatric apheresis devices. For example, the US Food and Drug Administration (FDA) is actively fostering collaboration and communication among stakeholders to advance pediatric-specific medical device development, including apheresis devices. This focus on tailored solutions could not only enhance the quality of care in pediatric apheresis procedures but also drive increased adoption, thereby fueling the growth of the Apheresis Market.

Global Apheresis Market (2024-30): Segmentation Analysis

The Global Apheresis Market study by MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024–2030 at the regional level. In accordance to the analysis, the market has been further classified as:

Based on the Apheresis Procedure:

• Leukapheresis
• Plasmapheresis
• Plateletpheresis
• Erythrocytapheresis
• Others

Of them all, the Plasmapheresis segment held a major market share in the Global Apheresis Market. Individuals across the globe have been suffering from autoimmune diseases & neurological disorders due to genetic predispositions & changing lifestyles. For instance,

• As per the Multiple Sclerosis International Federation, the number of patients with Multiple Sclerosis has increased from 2.8 million in 2020 to 2.9 in 2023.

This procedure helps in removing inflammatory factors, autoantibodies, and other potentially harmful substances from the bloodstream. Consequently, this reduces the severity and duration of multiple sclerosis relapses. Therefore, healthcare professionals prescribe that consumers dealing with these disorders to go through plasmapheresis, driving the segmental market growth.

Further, this therapeutic procedure offers higher efficacy & safety, which improves the trust among the consumers, contributing significantly to the growth of the market.

Based on End User:

• Hospitals
• Blood Banks
• Research Organisations

Among them, Hospitals hold a noteworthy market share in the Global Apheresis Market. Apheresis machines are of high cost, therefore, independent blood banks & research institutes are unable to afford them. Moreover, the healthcare facilities are funded by both government & non-government organizations. As a result, there is no financial constraint for the hospital and they increasingly purchase the machines. Additionally, the application of these machines is higher in hospitals since even at the slightest health issues consumers increasingly prefer to go to the hospital for a complete check. The reliance of the individuals on the hospitals results in increased hospitalization rates. As a result, the demand for these machines is relatively higher in the healthcare units.

Further, with the rising heath expenditures across the globe, more hospitals are expected to be set up to serve a higher number of patients. These units are expected to serve large populations, including those requiring apheresis procedures, thereby, increasing the demand for medical equipment such as apheresis machines.

Global Apheresis Market (2024-30): Regional Projection

Geographically, the Global Apheresis Market expands across:

• North America
• South America
• Europe
• The Middle East & Rest of Africa
• Asia-Pacific

Geographically, North America holds a prominent market share in the Global Apheresis Market. North American countries have high occurrences of chronic diseases and the presence of a large patient population with hematological diseases. For instance,

• As per the Global Cancer Observatory, about 71.7 thousand new cases of leukemia were reported in 2022 in the North America region.
• Similarly, the Centers for Disease Control and Prevention (CDC) also mentioned in 2023 that sickle cell disease (SCD) affects approximately 100,000 Americans.

This necessitates the requirement for the best therapeutic solutions, propelling the North American Apheresis Market. Further, the per capita of consumers in these countries is increasing due to which health expenditure of these countries has also significantly grown. The rising economic growth is resulting in individuals opting for advanced therapies, uplifting market growth.

Additionally, sickle cell disease and leukemia among other blood disorders are also consistently rising in North America. Therefore, to address these disorders effectively & reduce the complications associated with these diseases, the demand for apheresis would continue to grow in thae forecast period.

Global Apheresis Industry Recent Development:

• 2022: Terumo Corporation announced that UK’s NHS England has selected the automated red blood cell exchange (RBCX) procedure performed on the company’s Spectra Optia® Apheresis System through the NHS MedTech Funding Mandate (MTFM) to treat sickle cell disease.

Gain a Competitive Edge with Our Global Apheresis Market Report

• The Global Apheresis Market Report by Markntel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• The Global Apheresis Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.